Retraction
Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression
Paper Information
Record ID:
32219
Author(s):
Journal:
Publication Date:
March 13, 2020
Retraction Date:
September 09, 2021
(4.2 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations6
Post-Retraction(46.2%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
1
After 2+ years
1252
Days since retraction (latest)
Downregulation of HDGF Inhibits Tumorigenic Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Suppressing the AKT/mTOR/VEGF pathway
Ziyang Liu, Qin Wang, Feilong Yang
Research Square (Research Square)
Published: Feb 2025
1252 days after retraction
LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918
Qifeng Yang, Long Wang, Xuechuang Han et al. (6 authors)
Biochemical and Biophysical Research Communications
Published: Jun 2023
3 citations
3 citations
649 days after retraction
Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma
Hua Liu, Chenyu Zong, Jiacheng Sun et al. (10 authors)
Translational Pediatrics
Open Access
Published: Jul 2022
5 citations
5 citations
295 days after retraction
LncRNA ASB16-AS1 drives proliferation, migration, and invasion of colorectal cancer cells through regulating miR-185-5p/TEAD1 axis
Mingxu Yu, Changsheng Shi, Dingyin Xu et al. (9 authors)
Cell Cycle
Open Access
Published: Dec 2021
14 citations
14 citations
88 days after retraction
Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer
Jiani Guo, Xuesong Yi, Zhuqing Ji et al. (7 authors)
Journal of Oncology
Open Access
Published: Nov 2021
7 citations
7 citations
79 days after retraction
Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
Linyong Wu, Wei Liao, Xiaodong Wang et al. (8 authors)
Bioengineered
Open Access
Published: Oct 2021
7 citations
7 citations
49 days after retraction
CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760
Jianjun Yuan, Yan Liu, Quan Zhang et al. (6 authors)
Cancer Management and Research
Open Access
Published: Jun 2021
16 citations
16 citations
100 days before retraction
Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis
Congda Li, Xiangbo Lin, Caiyun Zhang et al. (6 authors)
Human Cell
Published: Apr 2021
15 citations
15 citations
139 days before retraction
miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression
Wei Liu, Dunwei Wang, Lidi Liu et al. (5 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Feb 2021
21 citations
21 citations
216 days before retraction
Long noncoding RNA ASB16-AS1 inhibits adrenocortical carcinoma cell growth by promoting ubiquitination of RNA-binding protein HuR
Bo Long, Xufei Yang, Xixia Xu et al. (7 authors)
Cell Death and Disease
Open Access
Published: Nov 2020
25 citations
25 citations
293 days before retraction
Long non-coding RNA ASB16-AS1 inhibits proliferation, migration, and invasion of gastric cancer cells by regulating miR-670-3p/ATXN7L3 axis
Jun Luo, Xiaoping Zhang, Yuanyuan Zheng et al. (4 authors)
Shijie huaren xiaohua zazhi
Open Access
Published: Aug 2020
398 days before retraction
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
Hirayuki Enomoto, Hideji Nakamura, Hiroki Nishikawa et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Jun 2020
16 citations
16 citations
453 days before retraction
Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation
Hirayuki Enomoto, Hideji Nakamura, Hiroki Nishikawa et al. (7 authors)
In Vivo
Open Access
Published: Jan 2020
4 citations
4 citations
617 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025